Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3

NCT04277338 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Primary Breast Cancer

Interventions

DRUG: SPECT

Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences

Collaborators

[object Object]
[object Object]